Innate Immunotheraputics Limited
Our People
Investment
Clinical Trials
Lead Candidate
Adjuvant
Contact Us
Subscribe to our RSS News Feed
Subscribe to our RSS feed with the following link:
News
Press Releases, News and Media
Media
Research
Home
Biopharmaceutical product development
Our People
Meet the team behind the research programmes
Investment
Company profile and future investment plans
Clinical Trials
Current trials and trial objectives
Lead Candidate
MIS416 - immune modulating microparticle
Microparticle Platform
A unique therapeutic microparticle
Adjuvant
Novel vaccine adjuvant for cellular immunity
Contact Us
Contact Innate Immunotherapeutics, Auckland, New Zealand
Subscribe to our RSS Feed
Research
Research Press Releases
Articles:
18/09/2011:
Oncology and Anti-infective patents lodged
View Article.